| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |